(VIANEWS) - Coastal Financial Corporation (CCB), MainStreet Bancshares (MNSB), Superior Industries International (SUP) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Coastal Financial Corporation (CCB)
65.2% sales growth and 16.34% return on equity
Earnings Per Share
As for profitability, Coastal Financial Corporation has a trailing twelve months EPS of $1.51.
PE Ratio
Coastal Financial Corporation has a trailing twelve months price to earnings ratio of 29.91. Meaning, the purchaser of the share is investing $29.91 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.34%.Growth Estimates Quarters
For the current quarter, the company expects to grow by 40.4% and 84% respectively.Sales Growth
Coastal Financial Corporation's sales growth is 106.3% for the ongoing quarter and 65.2% for the next.
Moving Average
Coastal Financial Corporation's worth is below its 50-day moving average of $48.26 and above its 200-day moving average of $42.54.2. MainStreet Bancshares (MNSB)
29.6% sales growth and 12.78% return on equity
MainStreet Bancshares, Inc. is the bank holding organization for MainStreet Bank. It provides various banking services and products for individuals, small and medium-sized business, as well as professional service organisations, primarily in Northern Virginia, Washington, DC, and greater Washington, D.C. metropolitan areas. It offers money market, demand, money market and sweep accounts as well certificates of deposit, interest-bearing and business checking. The company also offers commercial loans including plant and equipment, government contract receivables and contract administration; residential and commercial realestate loans and real estate construction loans. It also offers consumer loans that include car loans, term loans and credit cards. The company also offers payment services and deposit insurance, remote deposit of checks, payment service, payment management online, as well as online bill payment and cash management. The company operates seven branches in Virginia: Fairfax, Fairfax City and McLean. One branch is located in Washington DC. It also offers automated teller machine transactions at more than 55,000 locations across the United States, Canada and the United Kingdom. MainStreet Bancshares, Inc. is located in Fairfax, Virginia.
Earnings Per Share
As for profitability, MainStreet Bancshares has a trailing twelve months EPS of $2.87.
PE Ratio
MainStreet Bancshares has a trailing twelve months price to earnings ratio of 9.37. Meaning, the purchaser of the share is investing $9.37 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.78%.3. Superior Industries International (SUP)
27.1% sales growth and 6.36% return on equity
Superior Industries International, Inc. designs, manufactures, and sells aluminum wheels to the original equipment manufacturers and aftermarket distributors in North America and Europe. The company supplies aluminum wheels to the automobile and light truck manufacturers. It offers its products under the ATS, RIAL, ALUTEC, and ANZIO brand names. The company was founded in 1957 and is headquartered in Southfield, Michigan.
Earnings per Share
Superior Industries International's trailing twelve-month EPS is $-10.815.
For the 12 trailing months, the company's return-on-equity, which is an indicator of the business' profitability relative to shareholders' equity, was 6.36%.Moving Average
Superior Industries International's worth is under its 50-day moving average of $4.45 and above its 200-day moving average of $4.22.Volume
Superior Industries International's current reported volume is 31489, which is 62.96% lower than its average volume at 85032.
Yearly Top and Bottom Value
Superior Industries International's stock is valued at $4.23 at 00:22 EST, way below its 52-week high of $6.06 and way higher than its 52-week low of $2.88.
Growth Estimates Quarters
For the current quarter, the company expects to grow by 111.1% and 172.5% respectively.4. Exelixis (EXEL)
20% sales growth and 13.36% return on equity
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat advanced melanoma; and MINNEBRO, an oral non-steroidal selective blocker of the mineralocorticoid receptor for the treatment of hypertension in Japan. In addition, it is developing XL092, an oral tyrosine kinase inhibitor that targets VEGF receptors, MET, AXL, MER, and other kinases implicated in growth and spread of cancer; XB002, an antibody-drug conjugate composed of human mAb against tissue factor (TF) for the treatment of advanced solid tumors; XL102, an orally bioavailable cyclin-dependent kinase 7 (CDK7) inhibitor for the treatment of advanced or metastatic solid tumors; and XB002 for the treatment of non-hodgkin's lymphoma. Exelixis, Inc. has research collaborations and license agreements with Ipsen Pharma SAS; Takeda Pharmaceutical Company Ltd.; F. Hoffmann-La Roche Ltd.; Redwood Bioscience, Inc.; R.P. Scherer Technologies, LLC; Catalent Pharma Solutions, Inc.; NBE Therapeutics AG; Aurigene Discovery Technologies Limited; Iconic Therapeutics, Inc.; Invenra, Inc.; StemSynergy Therapeutics, Inc.; Genentech, Inc.; Bristol-Myers Squibb Company; and Daiichi Sankyo Company, Limited. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was incorporated in 1994 and is headquartered in Alameda, California.
Earnings Per Share
As for profitability, Exelixis has a trailing twelve months EPS of $0.97.
PE Ratio
Exelixis has a trailing twelve months price to earnings ratio of 16.54. Meaning, the purchaser of the share is investing $16.54 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.36%.Earnings Before Interest, Taxes, Depreciation, and Amortization
Exelixis's EBITDA is 41.73.
Revenue growth
The year-on-year revenue growth was 25.4%. It now stands at 1.64B in the 12 trailing months.
5. Iron Mountain Incorporated (IRM)
16.2% sales growth and 38.11% return on equity
Iron Mountain Incorporated, NYSE: IRM) was founded in 1951 and is a global leader in information storage. Iron Mountain is trusted by over 225,000 companies around the globe. With a network that spans more than 90,000,000 square feet and more than 1,480 locations in 50 countries, Iron Mountain protects and stores billions worth of valuable assets. This includes highly confidential data and artifacts from history and culture. Iron Mountain offers solutions such as secure records storage, data management, digital transformation and secure destruction. It also provides cloud services, art storage and logistics. This helps customers reduce cost, risk and comply with regulations.
Earnings per Share
Iron Mountain Incorporated's trailing twelve-month EPS is $1.19.
PE Ratio
Iron Mountain Incorporated's trailing 12 months earnings to price ratio is 42.49. The purchaser of the shares is therefore investing $42.49 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 38.11%.Revenue Growth
Year-on-year quarterly revenue growth grew by 15.2%, now sitting on 4.83B for the twelve trailing months.
6. Columbia Financial (CLBK)
14.5% sales growth and 8.5% return on equity
Columbia Financial, Inc. operates as the bank holding company for Columbia Bank that provides financial services to businesses and consumers in the United States. The company offers non-interest-bearing demand deposits, such as individual and commercial checking accounts; interest bearing demand accounts comprising interest earning checking accounts and municipal accounts; and savings and club accounts, money market accounts, and certificates of deposit. It also provides loans, including multifamily and commercial real estate loans, commercial business loans, one- to four-family residential loans, construction loans, home equity loans and advances, and other consumer loans that include automobiles and personal loans, as well as unsecured and overdraft lines of credit. In addition, the company offers title insurance products; wealth management services; and cash management services, including remote deposit, lockbox service, and sweep accounts. As of December 31, 2020, it operated 61 full-service banking offices in twelve of New Jersey's 21 counties. The company was founded in 1927 and is headquartered in Fair Lawn, New Jersey. Columbia Financial, Inc. is a subsidiary of Columbia Bank MHC.
Earnings per Share
Columbia Financial's trailing 12 months earnings per share (EPS) is $0.65
PE Ratio
Columbia Financial's trailing 12-month price-earnings ratio is 33.49. The purchaser of the shares is therefore investing $33.49 per dollar in annual earnings.
Return on Equity, which is a measure of profitability relative to shareholders equity for the 12 trailing months, was 8.5%.7. Marathon Oil (MRO)
10.1% sales growth and 28% return on equity
Marathon Oil Corporation is an independent exploration company that produces oil and gas in the United States as well as internationally. It is involved in exploration, production, marketing, and distribution of crude oil, condensate and natural gas liquids and natural gas. The company also produces and markets products made from natural gas such as liquefied gas and methanol. The company also has 32 central gathering facilities and treatment facilities. It also operates the Sugarloaf gathering network, a 42-mile natural gaz pipeline that runs through Karnes County and Atascosa Counties. In December 2001, the company changed its name from USX Corporation to Marathon Oil Corporation. Marathon Oil Corporation was established in 1887. It is located in Houston, Texas.
Earnings per Share
Marathon Oil's trailing 12 month EPS is $-1.83.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability of a company relative to shareholders' equity, was 28%.Revenue growth
The year-on-year revenue growth was 73.1%. We now have 7.13B in the 12 trailing months.
Annual Top and Bottom Value
Marathon Oil stock was valued at $27.15 at 02:22 EST at 00.22 EST. This is way below its 52-week peak of $33.42 but way higher than its low 52-week of $17.02.
8. Novanta (NOVT)
6.9% sales growth and 13.92% return on equity
Novanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. Its Photonics segment offers photonics-based solutions, including laser scanning and beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products for photonics-based applications, such as industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. The company's Vision segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless, recorder, and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions. Its Precision Motion segment offers optical and inductive encoders, precision motors, motion control sub-assemblies, servo drives, air bearings, and air bearing spindles. The company sells its products through its direct sales force, resellers, distributors, and system integrators under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was founded in 1968 and is headquartered in Bedford, Massachusetts.
Earnings per Share
Novanta's trailing 12 month EPS is $1.97.
PE Ratio
Novanta's trailing 12 months earnings to price ratio is 71.6. The purchaser of shares is therefore investing $71.6 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 13.92%.